The pharmacotherapy options for the intensive treatment phase in patients with primarily diagnosed pulmonary tuberculosis

M. Kuzhko, N. Hulchuk, M. Gumeniuk, M. Klymenko, O. Avramchuk, O. Denisov (Kiyv, Ukraine)

Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Session: Tuberculosis: clinical findings II
Session type: Thematic Poster Session
Number: 2605
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Kuzhko, N. Hulchuk, M. Gumeniuk, M. Klymenko, O. Avramchuk, O. Denisov (Kiyv, Ukraine). The pharmacotherapy options for the intensive treatment phase in patients with primarily diagnosed pulmonary tuberculosis. Eur Respir J 2012; 40: Suppl. 56, 2605

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Features of intravenous anti TB therapy in patients with first diagnosed pulmonary TB in the intensive phase of treatment
Source: International Congress 2017 – MDRTB: detection and management
Year: 2017

Effectiveness of the intensive phase of chemotherapy in pulmonary TB patients with primary drug resistance
Source: Eur Respir J 2006; 28: Suppl. 50, 290s
Year: 2006

Diagnosis and treatment delay in patients with pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 520s
Year: 2003

Isophonum usage in treatment of patients with pulmonary tuberculosis and accompanying pathology and elderly patients
Source: Eur Respir J 2002; 20: Suppl. 38, 547s
Year: 2002

Treatment effectiveness among newly diagnosed patients with expanded pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 367s
Year: 2002

Treatment outcomes under early correction of chemotherapy in adolescents with advanced pulmonary TB
Source: Annual Congress 2007 - Clinical tuberculosis
Year: 2007


Application of psychotherapy in medical treatment of patients with first revealed pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 504s
Year: 2006

Efficacy of different preoperational treatment in patients with destructive pulmonary TB
Source: Eur Respir J 2005; 26: Suppl. 49, 688s
Year: 2005

Efficiency of treatment regimens for chronic tuberculosis patients
Source: Eur Respir J 2003; 22: Suppl. 45, 519s
Year: 2003

The evaluation of the relapse or treatment interrupted pulmonary tuberculosis cases
Source: Eur Respir J 2006; 28: Suppl. 50, 21s
Year: 2006

Clinical efficacy of new anti-TB drug ²tubelon² during complex chemotherapy in patients with first-time diagnosed destuctive pulmonary TB
Source: Eur Respir J 2006; 28: Suppl. 50, 8s
Year: 2006

Treatment patients with pulmonary tuberculosis (PT) and accompanying pathologies by DOTS strategy
Source: Eur Respir J 2005; 26: Suppl. 49, 192s
Year: 2005

Do empiric antibiotics delay appropriate antituberculosis medication in patients with active pulmonary tuberculosis?
Source: Annual Congress 2008 - Problems in managing pulmonary and extrapulmonary tuberculosis
Year: 2008

Surgical treatment of first found pulmonary tuberculosis at ineffectiveness of DOTS therapy
Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions
Year: 2011

The use of plasmapheresis in the treatment of patients with IY stage of pulmonary sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 434s
Year: 2002

Comparison of the effectiveness of two schedules of pulmonary rehabilitation in patients with severe COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 555s
Year: 2006

Efficiency of standard chemotherapy of patients with pulmonary TB with relapses and treatment failure at drug resistance of M. tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 339s
Year: 2001

Alternate diagnosis in clinically diagnosed pulmonary tuberculosis patients treated at tertiary care hospital in a high TB burden country
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020


A randomized study of the bronchoscopic valve blockade of the affected part of the lung in the complex treatment of patients with cavitary drug-resistant pulmonary tuberculosis with treatment failure
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013

Our clinical experience in surgical therapy of patients with bronchiectasis
Source: Eur Respir J 2002; 20: Suppl. 38, 344s
Year: 2002